BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
NHS National Proprietary Pharmaceuticals - Intravenous (IV) Fluids, Topical Solutions, Urological Solutions & Gelatins - CM/PHR/25/5727
Period of Framework Agreement: 1 June 2026 to 31 May 2028 with an option or option(s) to extend (at the Authority's discretion) for a period or periods up to a total of 24 months.
CM/PHR/25/5727/01 - High Use Lines Regionally Awarded to 1 Supplier
CM/PHR/25/5727/02 - Not Regionally Awarded Lines
CM/PHR/25/5727/03 - All Lines in Lot 1 and Lot 2, available only to Aseptic Units from any Supplier
CM/PHR/25/5727/04 - Added Value Services
No supplier information available.
This procurement was divided into 4 lots, each awarded separately.
| Lot | Value | Status |
|---|---|---|
| Lot 1 Lot 1 - CM/PHR/25/5727/01 Jun 2026 – May 2028 | £126,000,000 | cancelled |
| Lot 2 Lot 2 - CM/PHR/25/5727/02 Jun 2026 – May 2028 | £231,000,000 | complete |
| Lot 3 Lot 3 - CM/PHR/25/5727/03 Jun 2026 – May 2028 | £126,000,000 | complete |
| Lot 4 Lot 4 - CM/PHR/25?5727/04 Jun 2026 – May 2028 | £1 | complete |
Weightings from the notice, applied to every lot.
Changes the buyer published to this notice after it first appeared.
PLEASE IGNORE
THIS HAS BEEN PUBLISHED IN ERROR